摘要:
The present invention relates to peptides having an immunomodulatory activity. The present invention is concerned with the tetrapeptide H-Lys-Asn-Pro-Tyr-OH (SEQ.ID NO:1) and analogues thereof as immunomodulators. The present invention also includes the use of such peptides as vaccine adjuvant.
摘要:
Tricyclic heteronaphthoquinone derivatives, that have antineoplastic activity, are disclosed, together with processes for their synthesis. Some of these anti-neoplastics compounds have a saccharide moiety. Some members of this structurally distinct group exhibit activity against multiple drug resistant cancer cells.
摘要:
Cette invention se rapporte à de nouveaux peptides linéaires ainsi qu'à leurs mélanges et combinaisons chimiques efficaces pour détecter et quantifier les infections par HTLV-I et HTLV-II. Ces peptides sont efficaces également dans des vaccins contre des infections virales par HTLV-I et HTLV-II.
摘要:
The present invention relates to highly diastereoselective processes for production of cis -nucleotides and nucleoside analogues and derivatives in high optical purity and intermediates useful in those processes.
摘要:
This invention relates to novel peptides and mixtures thereof useful for detecting HCV infections. These peptides are also useful as active ingredients in vaccines against HCV infection.
摘要:
Disclosed are processes for preparing compounds of formula (I) and pharmaceutically acceptable salts or esters thereof, wherein R2 is a purine or pyrimidine base or an analogue or derivative thereof; and Z is S, S = O or SO2. The invention also relates to intermediates of use in the preparation of these compounds.
摘要:
The invention relates to 1,3-oxathiolane nucleoside analogues and their use in the treatment of viral infections. More specifically, this invention relates to (-)-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one and pharmaceuticall acceptable derivatives and pharmaceutical formulations thereof.